XML 73 R57.htm IDEA: XBRL DOCUMENT v3.25.4
Acquisitions and Dispositions - Income Statement Disclosure (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Other income and expense:      
Income from discontinued business $ 0 $ 223,414 $ 242,632
Income tax expense from discontinued business 0 (56,697) (53,372)
Income from discontinued operations, net of tax 0 166,717 189,260
Income from discontinued operations, net of tax, attributable to Select Medical Holdings Corporation’s common stockholders $ 0 148,565 184,464
Concentra Group Holdings Parent | Discontinued Operations      
Sale of Businesses      
Revenue   1,738,411 1,838,081
Costs and expenses:      
Cost of services, exclusive of depreciation and amortization   1,374,783 1,477,648
General and administrative   1,620 0
Depreciation and amortization   61,028 73,051
Total costs and expenses   1,437,431 1,550,699
Other operating income   284 250
Income from operations   301,264 287,632
Other income and expense:      
Equity in earnings of unconsolidated subsidiaries   (3,676) (526)
Interest expense   (59,513) (44,474)
Income from discontinued business   238,075 242,632
Income tax expense from discontinued business   (56,756) (53,372)
Income from discontinued operations, net of tax   181,319 189,260
Less: Net income attributable to non-controlling interests   18,152 4,796
Income from discontinued operations, net of tax, attributable to Select Medical Holdings Corporation’s common stockholders   163,167 184,464
Allocated interest expense, intercompany debt   $ 22,000 $ 44,300